Elsevier, the information analytics company specialising in science and health, has announced the publication of Translating Epigenetics to the Clinic, edited by Dr. Jeffrey Laurence. One of three new regenerative medicine titles, the book concentrates on the latest knowledge, laboratory technique and experimental approaches used by translational research leaders in this field. Promoting cross-disciplinary communication between medical sub-specialties, it emphasises recent innovations, critical barriers to progress, and the new tools being used to overcome them.
Translating Epigenetics to the Clinic organises epigenetics into disease treatment areas with a major focus on oncology, and with broad coverage of pervasive treatment categories such as diabetes, as well as 'diseases of modernity' - including pharmacological addiction, dementia and aging. The book also identifies specific areas of research that require additional study to advance the field as a whole.
The three new regenerative medicine titles are: Translating Epigenetics to the Clinic, edited by Jeffrey Laurence; Biology and Engineering of Stem Cell Niches, edited by Ajaykumar Vishwakarma and Jeffrey Karp; and Bioprinting: Techniques and Risks for Regenerative Medicine by Maika G. Mitchell
In order to meet content needs in regenerative medicine, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books will educate the next generation of researchers and clinicians, and provide critical foundational content for information professionals.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
